Is cytokine-induced sensorineural hearing loss reversible?
Imashuku
Shinsaku
S
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects*; D020127:Recovery of Function
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein